Skip to main content

Market Overview

Jounce Therapeutics, Inc. (JNCE)

10.98 -0.78 (-6.63%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2021
Pre-Market
EPS:
REV:




Q3 2021
Pre-Market
EPS:
REV:
-0.73
0



Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.78
0



Q4 2020
Pre-Market
EPS:
REV:
-0.68
0
0.22
39.27M
0.86
62.339M
290.91%
58.74%
Q3 2020
Pre-Market
EPS:
REV:
2.9
119.445M
-0.47
2.97M
-0.73
0
-55.32%
-100%
Q2 2020
Pre-Market
EPS:
REV:
-0.21
17.446M
-0.72
-0.82
0
-13.89%
Q1 2020
Pre-Market
EPS:
REV:
-0.38
10.981M
-0.57
1.67M
-0.78
0
-36.84%
-100%
Q4 2019
Pre-Market
EPS:
REV:
-0.06
20.1M
-0.31
15M
-0.68
0
-119.35%
-100%
Q3 2019
Pre-Market
EPS:
REV:
-0.23
14.528M
2.24
102.34M
2.9
119.445M
29.46%
16.71%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!